Advanced Enzyme Technologies Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹203.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.27 per cent from ₹171.95 crore. This corresponds to a year-on-year *(YoY) growth of 21.65 per cent.
Operating Profit
Operating Profit stands at ₹63.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.13 per cent from ₹49.35 crore. This corresponds to a year-on-year *(YoY) growth of 38.66 per cent.
PBDT
PBDT stands at ₹69.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.18 per cent from ₹68.50 crore. This corresponds to a year-on-year *(YoY) growth of 30.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹59.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.59 per cent from ₹58.29 crore. This corresponds to a year-on-year *(YoY) growth of 37.60 per cent.
Net Profit
Net Profit stands at ₹45.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.79 per cent from ₹43.18 crore. This represents a 69.29 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Advanced Enzyme Technologies Ltd Earnings
- YOY
- QOQ
Advanced Enzyme Technologies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Advanced Enzyme Technologies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Advanced Enzyme Technologies Ltd Financial Reports
Advanced Enzyme Technologies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Advanced Enzyme | -0.31% | 5.97% | 29.54% | 23.34% | 22.02% | 33.75% |
| SPARC | -0.25% | 5.19% | 24.48% | 40.31% | 31.85% | 8.01% |
| Innova Captab | 1.09% | 1.55% | 22.51% | 30.36% | 16.39% | 0.20% |
| Senores Pharma. | 2.38% | 12.80% | 20.05% | 35.75% | 31.66% | 109.09% |
| Guj. Themis Bio. | 0.58% | -4.81% | 8.37% | 6.98% | -13.25% | 14.74% |
| SMS Pharma. | 1.81% | 4.10% | 2.00% | 10.92% | 47.50% | 57.98% |
| RPG LifeScience. | -0.04% | -2.15% | 15.10% | 20.67% | 2.02% | 6.02% |
Company Info
Company Information
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Executive & Non-Independent Director : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Executive & Non-Independent Director : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.